XML 86 R50.htm IDEA: XBRL DOCUMENT v3.20.4
DEBT (Details Narrative)
3 Months Ended 12 Months Ended
Mar. 01, 2021
USD ($)
Apr. 24, 2019
USD ($)
Number
May 01, 2018
USD ($)
Number
Dec. 31, 2020
USD ($)
shares
Sep. 30, 2020
USD ($)
Jun. 30, 2020
USD ($)
Mar. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Sep. 30, 2019
USD ($)
[6]
Jun. 30, 2019
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Nov. 08, 2021
$ / shares
Nov. 08, 2020
USD ($)
$ / shares
Aug. 05, 2020
USD ($)
$ / shares
shares
Debt Instrument [Line Items]                                  
Revenues       $ 22,577,000 [1] $ 19,343,000 [2],[3],[4],[5] $ 10,701,000 $ 12,251,000 $ 15,902,000 $ 23,719,000 $ 6,079,000 [7] $ 3,947,000 $ 64,872,280 $ 49,646,937 $ 16,099,460      
Repayments of Lines of Credit                       81,660,719      
Minimum cash balance requirement under credit agreement       $ 60,000,000               $ 60,000,000          
Number of warrants issued | shares       6,534,687               6,534,687          
Shares Issued, Price Per Share | $ / shares                             $ 1.1856    
Gain (Loss) on Extinguishment of Debt                   $ (10,100,000)   (10,057,632)      
Amortization of deferred financing costs                       2,256,429 856,302 269,859      
Write off of deferred financing fees                       275,379      
Lender Warrants [Member]                                  
Debt Instrument [Line Items]                                  
Number of warrants issued | shares                                 4,752,116
Warrants exercise price | $ / shares                                 $ 1.58
Fair value of warrants         7,400,000                       $ 7,428,178
Financing Agreement Amendment No. 6 [Member]                                  
Debt Instrument [Line Items]                                  
Minimum cash balance requirement under credit agreement                               $ 45,000,000  
Debt discount                               $ 239,983  
Financing Agreement Amendment No. 6 [Member] | Lender Warrants [Member]                                  
Debt Instrument [Line Items]                                  
Warrants exercise price | $ / shares                               $ 1.1856  
Financing Agreement [Member]                                  
Debt Instrument [Line Items]                                  
Amortization of deferred financing costs                       2,256,428 736,156        
Long-term Debt, Gross       $ 250,000,000       200,000,000       250,000,000 200,000,000        
Debt Issuance Costs, Gross       $ 7,902,270               7,902,270          
Interest Expense, Borrowings                       $ 26,049,236 14,709,166        
Debt Instrument, Interest Rate, Effective Percentage       12.50%               12.50%          
IMVEXXY, BIJUVA and ANNOVERA [Member] | Subsequent Event [Member] | Financing Agreement Amendment No. 8 - First quarter of 2021 [Member]                                  
Debt Instrument [Line Items]                                  
Minimum revenue requirement under credit agreement $ 17,000,000                                
IMVEXXY, BIJUVA and ANNOVERA [Member] | Subsequent Event [Member] | Financing Agreement Amendment No. 8 - Second quarter of 2021 [Member]                                  
Debt Instrument [Line Items]                                  
Minimum revenue requirement under credit agreement 20,000,000                                
IMVEXXY, BIJUVA and ANNOVERA [Member] | Subsequent Event [Member] | Financing Agreement Amendment No. 8 - Third quarter of 2021 [Member]                                  
Debt Instrument [Line Items]                                  
Minimum revenue requirement under credit agreement 23,000,000                                
IMVEXXY, BIJUVA and ANNOVERA [Member] | Subsequent Event [Member] | Financing Agreement Amendment No. 8 - Fourth quarter of 2021 [Member]                                  
Debt Instrument [Line Items]                                  
Minimum revenue requirement under credit agreement 26,500,000                                
IMVEXXY, BIJUVA and ANNOVERA [Member] | Subsequent Event [Member] | Financing Agreement Amendment No. 8 - First quarter of 2022 [Member]                                  
Debt Instrument [Line Items]                                  
Minimum revenue requirement under credit agreement 30,000,000                                
IMVEXXY, BIJUVA and ANNOVERA [Member] | Subsequent Event [Member] | Financing Agreement Amendment No. 8 - Second quarter of 2022 [Member]                                  
Debt Instrument [Line Items]                                  
Minimum revenue requirement under credit agreement 35,000,000                                
IMVEXXY, BIJUVA and ANNOVERA [Member] | Subsequent Event [Member] | Financing Agreement Amendment No. 8 - Third quarter of 2022 [Member]                                  
Debt Instrument [Line Items]                                  
Minimum revenue requirement under credit agreement 40,000,000                                
IMVEXXY, BIJUVA and ANNOVERA [Member] | Subsequent Event [Member] | Financing Agreement Amendment No. 8 - Fourth quarter of 2022 [Member]                                  
Debt Instrument [Line Items]                                  
Minimum revenue requirement under credit agreement 45,000,000                                
IMVEXXY, BIJUVA and ANNOVERA [Member] | Subsequent Event [Member] | Financing Agreement Amendment No. 8 - First quarter of 2023 [Member]                                  
Debt Instrument [Line Items]                                  
Minimum revenue requirement under credit agreement 50,000,000                                
IMVEXXY, BIJUVA and ANNOVERA [Member] | Subsequent Event [Member] | Financing Agreement Amendment No. 8 - Second quarter of 2023 [Member]                                  
Debt Instrument [Line Items]                                  
Minimum revenue requirement under credit agreement 55,000,000                                
IMVEXXY, BIJUVA and ANNOVERA [Member] | Subsequent Event [Member] | Financing Agreement Amendment No. 8 - Third quarter of 2023 [Member]                                  
Debt Instrument [Line Items]                                  
Minimum revenue requirement under credit agreement 60,000,000                                
IMVEXXY, BIJUVA and ANNOVERA [Member] | Subsequent Event [Member] | Financing Agreement Amendment No. 8 - Fourth quarter of 2023 [Member]                                  
Debt Instrument [Line Items]                                  
Minimum revenue requirement under credit agreement 65,500,000                                
IMVEXXY, BIJUVA and ANNOVERA [Member] | Subsequent Event [Member] | Financing Agreement Amendment No. 8 - First quarter of 2024 [Member]                                  
Debt Instrument [Line Items]                                  
Minimum revenue requirement under credit agreement 70,000,000                                
IMVEXXY, BIJUVA and ANNOVERA [Member] | Minimum [Member]                                  
Debt Instrument [Line Items]                                  
Revenues               $ 11,000,000                  
Tranche Two [Member]                                  
Debt Instrument [Line Items]                                  
Debt Issuance Costs, Gross       $ 7,626,891               $ 7,626,891          
Financing Agreement [Member]                                  
Debt Instrument [Line Items]                                  
Debt Instrument, Description of Variable Rate Basis   3-month LIBOR                              
Debt Instrument, Basis Spread on Variable Rate   7.75%                              
LIBOR floor rate   2.70%                              
Number of quarterly principal installment payments | Number   4                              
Facility fee paid (percent)   2.50%                              
Minimum cash balance requirement under credit agreement   $ 60,000,000                              
Financing Agreement [Member] | Prime Rate [Member]                                  
Debt Instrument [Line Items]                                  
Debt Instrument, Description of Variable Rate Basis   prime rate                              
Debt Instrument, Basis Spread on Variable Rate   6.75%                              
Prime rate floor   5.20%                              
Financing Agreement [Member] | Tranche Two [Member]                                  
Debt Instrument [Line Items]                                  
Line of Credit Facility, Maximum Borrowing Capacity   $ 50,000,000                              
Financing Agreement [Member] | Tranche Three [Member]                                  
Debt Instrument [Line Items]                                  
Line Of Credit Facility Undrawn Tranche No Longer Available   $ 50,000,000     $ 50,000,000                        
Financing Agreement Amendment No 8 [Member] | Subsequent Event [Member]                                  
Debt Instrument [Line Items]                                  
Repayments of Lines of Credit $ 15,000,000                                
Prepayment fee percentage 5.00%                                
Financing Agreement Amendment No 8 [Member] | Subsequent Event [Member] | Repayment by March 31, 2021 [Member]                                  
Debt Instrument [Line Items]                                  
Prepayment fee percentage 5.00%                                
Principal repayment $ 35,000,000                                
Financing Agreement Amendment No 8 [Member] | Subsequent Event [Member] | Repayments on March 31, 2022, June 30, 2022 and September 30, 2022 [Member]                                  
Debt Instrument [Line Items]                                  
Principal repayment 5,000,000                                
Financing Agreement Amendment No 8 [Member] | Subsequent Event [Member] | Repayments on December 31, 2022 and March 31, 2023 [Member]                                  
Debt Instrument [Line Items]                                  
Principal repayment 10,000,000                                
Financing Agreement Amendment No 8 [Member] | Subsequent Event [Member] | Repayments on June 30, 2023, September 30, 2023, December 31, 2023 and March 31, 2024 [Member]                                  
Debt Instrument [Line Items]                                  
Principal repayment $ 41,250,000                                
Financing Agreement Amendment No 8 [Member] | Subsequent Event [Member] | Repayments through March 31, 2022 [Member]                                  
Debt Instrument [Line Items]                                  
Prepayment fee percentage 30.00%                                
Financing Agreement Amendment No 8 [Member] | Subsequent Event [Member] | Repayment on March 31, 2022 [Member]                                  
Debt Instrument [Line Items]                                  
Prepayment fee percentage 5.00%                                
Principal repayment $ 5,000,000                                
Financing Agreement Amendment No 8 [Member] | Subsequent Event [Member] | Repayments from April 1, 2022 through March 31, 2023 [Member]                                  
Debt Instrument [Line Items]                                  
Prepayment fee percentage 5.00%                                
Financing Agreement Amendment No 8 [Member] | Subsequent Event [Member] | Repayments from April 1, 2023 through March 31, 2024 [Member]                                  
Debt Instrument [Line Items]                                  
Prepayment fee percentage 3.00%                                
Credit Agreement [Member]                                  
Debt Instrument [Line Items]                                  
Prepayment fee percentage   4.00%                              
Repayment of debt with new credit facility   $ 81,661,000                              
Repayment fee percentage   4.00%                              
Interest Expense, Debt                         1,816,747 4,407,975      
Amortization of deferred financing costs                         $ 120,146 $ 269,859      
Revolving Credit Facility [Member] | Financing Agreement [Member]                                  
Debt Instrument [Line Items]                                  
Line of Credit Facility, Maximum Borrowing Capacity   $ 300,000,000                              
Secured Debt [Member]                                  
Debt Instrument [Line Items]                                  
Line of Credit Facility, Maximum Borrowing Capacity   $ 200,000,000 $ 200,000,000                            
Debt Instrument, Description of Variable Rate Basis     one-month LIBOR                            
Debt Instrument, Basis Spread on Variable Rate     7.70%                            
LIBOR floor rate     1.50%                            
Number of tranches under term loan facility | Number     3                            
[1] During the fourth quarter of 2020, we wrote off approximately $0.5 million in costs related to trademarks and patents. Refer to discussion in Note 6-Intangible Assets, Net.
[2] During the third quarter of 2020, we recorded $2 million in license revenue related to the Knight License Agreement. Refer to discussion in Note 2-Summary of Significant Accounting Policies.
[3] During the third quarter of 2020, we recorded approximately $5.7 million in inventory charge, primarily related to BIJUVA. Refer to discussion in Note 2-Summary of Significant Accounting Policies.
[4] During the third quarter of 2020, we recorded the fair value of the Lender Warrants based on Amendment No. 5 of approximately $7.4 million as a debt discount, which is being amortized to interest expense using the effective interest method over the term of the Financing Agreement. Refer to discussion in Note 8-Debt.
[5] During the third quarter of 2020, we wrote off approximately $0.6 million in costs related to trademarks and patents. Refer to discussion in Note 6-Intangible Assets, Net.
[6] During the third quarter of 2019, we recorded approximately $15.5 million in license revenue related to the Theramex License Agreement. Refer to discussion in Note 2-Summary of Significant Accounting Policies.
[7] During the second quarter of 2019, we recorded approximately $10.1 million in loss on extinguishment of debt related to the repayment of the Credit Agreement. Refer to discussion in Note 8-Debt.